Clinical Trials Logo

Clinical Trial Summary

The objective of the study is to validate epigenetic changes as biomarkers in a prospective sampling of newborn blood samples collected at birth (umbilical cord blood) and during routine screening (heel stick blood) in newborns concurrently tested for alcohol exposure levels by PEth blood spot testing.

Clinical Trial Description

Fetal alcohol spectrum disorders (FASD) are a group of conditions that can occur in a person whose birth mother consumed alcohol during pregnancy. The effects can include physical problems and/or difficulties with behavior and learning. When clinicians identify FASD early, intervention approaches can minimize the potential impact and lessen or even prevent disabilities. Thus, objective markers for prenatal alcohol exposure are desired.

Using dried blood spots from the umbilical cord and a heel stick of newborns, this study will use Phosphatidylethanol (PEth), a novel biomarker for alcohol exposure, to identify and characterize infants' exposure to alcohol before birth. Additionally, the dried blood spots will used to validate the use of screening assays using epigenetic changes as markers for prenatal alcohol exposure. Epigenetic changes are heritable changes in DNA that affect DNA function but do not change DNA sequence. The use of PEth testing will allow for the correlation of prenatal alcohol exposure levels with epigenetic changes. Women will be consented prior to delivery for participation in this prospective study. The study will be conducted in collaboration with United States Drug Testing Laboratories, Inc. (USDTL). ;

Study Design

Related Conditions & MeSH terms

NCT number NCT03494738
Study type Observational
Source CAMC Health System
Contact Stefan Maxwell, MD
Phone 304-388-2238
Status Recruiting
Start date April 12, 2018
Completion date April 2020

See also
  Status Clinical Trial Phase
Completed NCT01961050 - Preventing FAS/ARND in Russian Children N/A
Completed NCT02457676 - Improving Self Regulation in Children With Fetal Alcohol Syndrome Spectrum Disorders: A Neuroplastic Intervention N/A
Recruiting NCT03361293 - Cognitive Training and tDCS for Children With FASD N/A
Completed NCT01911299 - Choline Supplementation in Children With Fetal Alcohol Spectrum Disorders Phase 2
Not yet recruiting NCT03852550 - READYorNot[TM] Brain-Based Disabilities Trial N/A
Recruiting NCT02735473 - Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders Phase 2
Completed NCT03782935 - Nutritional Risk Factors for FASD in Ukraine N/A
Completed NCT01149538 - Postnatal Choline Supplementation in Children With Prenatal Alcohol Exposure Phase 1/Phase 2
Recruiting NCT03342495 - Evaluating Innovations in Transition From Pediatric to Adult Care - The Transition Navigator Trial N/A
Completed NCT02128880 - Contraception and Alcohol Risk Reduction Internet Intervention Randomized Trial N/A
Recruiting NCT03524664 - A Study of Parent and Child Emotions in Fetal Alcohol Spectrum Disorder (FASD) N/A
Completed NCT01971398 - Development of Education Materials for Prevention of FAS in Russia N/A